Takase Ayae, Yasukawa Tsutomu, Kato Aki, Ogura Yuichiro
Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya-shi, Aichi 467-8601, Japan.
Graefes Arch Clin Exp Ophthalmol. 2008 Jul;246(7):989-92. doi: 10.1007/s00417-008-0794-7. Epub 2008 Mar 26.
The pathology of diabetic retinopathy involves endothelial dysfunction, in which leukocyte adhesion to the vascular endothelium via intercellular adhesion molecule-1 (ICAM-1) may play a key role. Short-interfering RNAs (siRNAs) are unique modulators of gene expression in mammalian cells. The purpose of this study was to evaluate the enhanced effect of hyperglycemia and the attenuating effect of siRNAs on ICAM-1 expression in cultured endothelial cells.
Human umbilical vein endothelial cells (HUVECs) were seeded onto 24-well culture plates. The following day, ICAM-1-specific siRNAs were transfected using Lipofectamine 2000. Glucose (15, 30, or 45 mM) or interleukin-1ss as a positive control was added to the medium to stimulate ICAM-1. After 48 hours, the HUVECs were collected to measure the ICAM-1 expression by enzyme-linked immunosolvent assay. Fluoresceinated siRNAs were transfected into HUVECs to confirm transfection of the siRNAs into HUVECs by fluorescein microscopy.
Glucose enhanced the ICAM-1 expression in a dose-dependent manner. ICAM-1 expression stimulated by hyperglycemia decreased significantly in the HUVECs transfected with corresponding siRNAs. Transfection of siRNAs was confirmed with enhanced fluorescence in HUVECs incubated with control siRNAs.
These results suggested that hyperglycemia stimulated protein expression of ICAM-1 and that siRNAs suppressed gene expression of ICAM-1 in HUVECs. The RNA-targeting approach using siRNAs may provide a novel therapeutic option for diabetic retinopathy.
糖尿病视网膜病变的病理学涉及内皮功能障碍,其中白细胞通过细胞间黏附分子-1(ICAM-1)黏附于血管内皮可能起关键作用。小干扰RNA(siRNA)是哺乳动物细胞中基因表达的独特调节剂。本研究的目的是评估高血糖对培养的内皮细胞中ICAM-1表达的增强作用以及siRNA的减弱作用。
将人脐静脉内皮细胞(HUVECs)接种到24孔培养板上。次日,使用Lipofectamine 2000转染ICAM-1特异性siRNA。向培养基中添加葡萄糖(15、30或45 mM)或白细胞介素-1β作为阳性对照以刺激ICAM-1。48小时后,收集HUVECs通过酶联免疫吸附测定法测量ICAM-1表达。将荧光素标记的siRNA转染到HUVECs中,通过荧光显微镜确认siRNA转染到HUVECs中。
葡萄糖以剂量依赖性方式增强ICAM-1表达。在用相应siRNA转染的HUVECs中,高血糖刺激的ICAM-1表达显著降低。在用对照siRNA孵育的HUVECs中,通过增强的荧光证实了siRNA的转染。
这些结果表明高血糖刺激了HUVECs中ICAM-1的蛋白表达,而siRNA抑制了ICAM-1的基因表达。使用siRNA的RNA靶向方法可能为糖尿病视网膜病变提供一种新的治疗选择。